We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 100000000
Delivery Lead Time: 1 week
Sample Provided: yes
Payment Terms: T/T
Scrianen folic acid tablet is a drug, the main role is to prevent fetal neural tube malformations (anencephaly, spina bifida); Prevention of fetal cleft lip and palate; Prevent birth defects such as congenital heart disease and other body surface malformations; Prevent anemia in pregnant women, nursing mothers and fetuses
Scrianen folic acid tablets, which are mainly used to prevent birth defects such as neural tube malformations, are the result of a 13-year, $20 million collaboration between the Chinese and American governments and 250,000 clinical observations. The results have been adopted by more than 50 countries in the world, and have been successively published in well-known peer-reviewed journals at home and abroad, such as The Lancet, The New England Journal of Medicine, the Chinese Medical Journal, and the Chinese Journal of Epidemiology. In 1997, the quality standard of 0.4mg folic acid proposed by the company was set as an international standard by the World Health Organization and was recorded by the Chinese Pharmacopoeia. In the same year, "Scrianen folic acid tablet" won the new drug certificate of the Ministry of Health, and was promoted to the whole country as a key project of "100 scientific and technological achievements in ten years" by the Ministry of Health of China. In 2003, it won the national Key new product certificate jointly issued by the Ministry of Science and Technology and other ministries and commissions, and was rated as "National key new product" by the Ministry of Science and Technology, the Ministry of Commerce and other five ministries.